Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117139) titled 'The effect of Lactobacillus rhamnosus LR607 combined with immune checkpoint inhibitors and platinum-based doublet chemotherapy in resectable stage II-IIIB non-small cell lung cancer: A single-arm, multi-center clinical trial' on Jan. 20.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Zhujiang Hospital of Southern Medical University
Condition:
Non-small cell lung cancer
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-01-31
Target Sample Size: Experimental group:52;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/show...